Ticagrelor CAS No. 274693-27-5

Luhan pharmachem Co., Ltd. supplies Ticagrelor bulk active pharmaceutical ingredient (API) to the pharmaceutical industry. Our Ticagrelor is manufactured by cGMP compliant facility. Welcome to contact us for further details including current DMF status for the product and up to date regulatory status of the manufacturing facility. We look forward to assisting you with your research and development projects.   What is Ticagrelor ? Ticagrelor is a platelet aggregation inhibitor produced by AstraZeneca. The drug was approved for use in the European Union by the European Commission on December 3, sovaldi 2010. The drug was approved by the US Food and Drug Administration on July 20, 2011.   Ticagrelor contains ticagrelor, a cyclopentyltriazolopyrimidine, inhibitor of platelet activation and aggregation mediated by the P2Y12 ADP-receptor. Chemically it is (1S,2S,3R,5S)-3-[7-{[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino}-5-(propylthio)-3H-[1, ask 2,3]-triazolo[4,5-d]pyrimidin-3-yl]-5-…

Pharmaceutical Selected Products Pharmaceutical Core Products Oral APIs Oncology APIs Oncology Intermediates